Form 8-K

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report: April 17, 2008

(Date of earliest event reported)

INTUITIVE SURGICAL, INC.

(exact name of registrant as specified in its charter)

 

Delaware   000-30713   77-0416458
(State or other jurisdiction
of incorporation or organization)
  Commission File Number   (I.R.S. Employer Identification No.)

1266 Kifer Road

Sunnyvale, California 94086

(Address of Principal executive offices, including zip code)

(408) 523-2100

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02. Results of Operations and Financial Condition.

On April 17, 2008, Intuitive Surgical, Inc. (“Intuitive”) issued a press release announcing its financial results for the quarter ended March 31, 2008. A copy of the press release is attached hereto as Exhibit 99.1.

The information in this Current Report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of Intuitive under the Securities Act of 1933 or the Exchange Act.

 

Item 9.01. Financial Statements and Exhibits.

d) Exhibits.

The following exhibit is furnished with this report on Form 8-K:

 

99.1    Press release issued by Intuitive Surgical, April 17, 2008.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    INTUITIVE SURGICAL, INC.
Date: April 17, 2008     By     /s/ Marshall L. Mohr
       

Name: Marshall L. Mohr

Title: Senior Vice President and

          Chief Financial Officer


EXHIBIT INDEX

 

Exhibit No.

  

Description

99.1    Press Release issued by Intuitive Surgical, April 17, 2008
Press release

Exhibit 99.1

 

FOR IMMEDIATE RELEASE    Contacts:    Ben Gong    408-523-2175
      Rae Covington    408-523-2161

INTUITIVE SURGICAL ANNOUNCES $188.2 MILLION FIRST QUARTER REVENUE, UP 65%

SUNNYVALE, CALIF. April 17, 2008 – Intuitive Surgical, Inc. (NASDAQ: ISRG), the industry leader in surgical robotics, today reported first quarter 2008 revenue of $188.2 million, increasing 65% from $114.2 million for the first quarter of 2007. First quarter 2008 revenue growth was driven by continued robotic procedure adoption and higher da Vinci® Surgical System sales.

First quarter 2008 instruments and accessories revenue increased 54% to $61.9 million from $40.3 million during the first quarter of 2007. First quarter 2008 da Vinci® Surgical Systems revenue increased 76% to $99.1 million from $56.1 million during the first quarter of 2007. First quarter 2008 service and training revenue increased 53% to $27.2 million from $17.8 million during the first quarter of 2007.

 

     Three Months Ended
March 31,

Revenue ($ Millions)

   2008    2007    Increase

Instruments/Accessories

   $ 61.9    $ 40.3    $ 21.6

Systems

     99.1      56.1      43.0

Service/Training

     27.2      17.8      9.4
                    
   $ 188.2    $ 114.2    $ 74.0
                    

First quarter 2008 operating income increased 89% to $64.9 million, compared with $34.3 million for the first quarter of 2007. Operating results for the first quarter of 2008 included $14.6 million of non-cash stock-based compensation expense in accordance with the Financial Accounting Standards Board SFAS 123R, compared with $8.1 million for the first quarter of 2007.

First quarter 2008 net income increased 88% to $44.8 million, compared with $23.8 million for the first quarter of 2007. Diluted earnings per share increased to $1.12 for the first quarter of 2008 from $0.62 for the first quarter of 2007.


Intuitive ended the first quarter of 2008 with cash, cash equivalents and investments of $700 million, up $64 million from December 31, 2007.

Commenting on the announcement, Lonnie Smith, Chairman and CEO of Intuitive Surgical, said, “We are pleased with our first quarter revenue and income growth. Our financial performance reflects the continued expansion of robotic surgical procedures and the compelling value we provide to patients and hospitals.”

The Company will also announce these results at a conference call today at 1:30 pm PDT. The dial-in numbers for the call are 877-909-3508 for participants located in the U.S. and 517-645-6051 for participants located outside the U.S. The passcode is ISRG and the meeting leader is Mr. Ben Gong. To access financial information that will be discussed on the call, please visit Intuitive Surgical’s website at www.intuitivesurgical.com.

About Intuitive’s Products:

The da Vinci® Surgical System consists of a surgeon’s viewing and control console having an integrated, high-performance InSite® 3-D, high definition vision system, a patient-side cart consisting of three or four robotic arms that position and precisely maneuver endoscopic instruments and an endoscope, and a variety of articulating EndoWrist® Instruments. By integrating computer-enhanced technology with surgeons’ technical skills, Intuitive believes that its system enables surgeons to perform better surgery in a manner never before experienced. The da Vinci® Surgical System seamlessly and directly translates the surgeon’s natural hand, wrist and finger movements on instrument controls at the surgeon’s console outside the patient’s body into corresponding micro-movements of the instrument tips positioned inside the patient through small puncture incisions, or ports.

Intuitive®, da Vinci®, da Vinci® S™, InSite®, and EndoWrist® are trademarks or registered trademarks of Intuitive Surgical, Inc.

# # #


This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are necessarily estimates reflecting the best judgment of our management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be considered in light of various important factors, including the following: timing and success of product development and market acceptance of developed products; regulatory approvals, clearances and restrictions; guidelines and recommendations in the health care and patient communities; intellectual property positions and litigation; competition in the medical device industry and in the specific markets of surgery in which Intuitive Surgical operates; and unanticipated manufacturing disruptions; delays in regulatory approvals of new manufacturing facilities or the inability to meet demand for products. Words such as “estimate”, “project”, “plan”, “intend”, “expect”, “anticipate”, “believe” and similar expressions are intended to identify forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We undertake no obligation to publicly update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.


INTUITIVE SURGICAL, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

(IN THOUSANDS, EXCEPT PER SHARE DATA)

 

     Three months ended
     March 31,
2008
   March 31,
2007

Revenue:

     

Products

   $ 160,951    $ 96,449

Services

     27,243      17,780
             

Total revenue

     188,194      114,229

Cost of revenue:

     

Products

     44,852      29,106

Services

     13,535      8,615
             

Total cost of revenue*

     58,387      37,721

Gross profit

     129,807      76,508

Operating expenses:

     

Selling, general and administrative

     48,634      33,945

Research and development

     16,301      8,224
             

Total operating expenses*

     64,935      42,169

Income from operations

     64,872      34,339

Interest and other income, net

     8,541      4,608
             

Income before income taxes

     73,413      38,947

Provision for income taxes

     28,632      15,145
             

Net lncome

   $ 44,781    $ 23,802
             

Earnings per share:

     

Basic

   $ 1.16    $ 0.64
             

Diluted

   $ 1.12    $ 0.62
             

Shares used in computing earnings per share:

     

Basic

     38,582      37,289
             

Diluted

     39,847      38,398
             

 

* Includes stock compensation expense of $2.2 million and $1.2 million in total cost of revenue and $12.3 million and $6.9 million in total operating expenses for the three months ended March 31, 2008 and 2007.


INTUITIVE SURGICAL, INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS)

 

     3/31/2008    12/31/2007

Cash, cash equivalents, and investments

   $ 699,654    $ 635,381

Accounts receivable, net

     135,690      130,370

Inventory

     38,832      32,416

Property and equipment, net

     71,905      68,093

Goodwill

     110,740      110,740

Deferred tax assets

     28,310      24,577

Other assets

     38,154      38,421
             

Total assets

   $ 1,123,285    $ 1,039,998
             

Accounts payable and other accrued liabilities

   $ 81,343    $ 96,632

Deferred revenue

     60,131      54,692
             

Total liabilities

     141,474      151,324

Stockholders’ equity

     981,811      888,674
             

Total liabilities and stockholders’ equity

   $ 1,123,285    $ 1,039,998